N1-Me-Pseudo UTP Trisodium solution

In the face of the unprecedented challenges posed by the COVID-19 pandemic, which has affected millions globally, N1-Methyl-Pseudouridine Triphosphate emerged as a key ingredient in the fight against the virus. As a critical RNA modification in the mRNA vaccines developed by Pfizer-BioNTech (Comirnaty®) and Moderna Therapeutics (Spikevax®), it has played a vital role in achieving efficacies surpassing 90%.

N1-Methyl-Pseudouridine Triphosphate represents a significant advancement in RNA-based therapeutics, offering a promising path forward not only in responding to pandemics but also in the broader field of vaccine research and development. Its impact on mRNA vaccine efficacy marks a turning point in medical science, showcasing the potential of innovative molecular approaches in combating global health crises.

• Chemical name: N¹-Methylpseudouridine 5′-Triphosphate Sodium Salt
• Molecular formula:C₁₀H₁₄N₂Na₃O₁₅P₃
• Molecular Weight: 564.11
• Cas NO.:1428903-59-6
• Grade: Injection, purity 99%
• Form: liquid
• Concentration: 100mM

Storage: -80°C, 6 months; -20°C, 1 month (protect from light)